Dawaa Reference

Clinical reference

Gangrene and Diabetic Foot (Emergency Referral)

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources7 sources

ADA Standards of Care in Diabetes 2024 · NICE Guideline NG19: Diabetic foot problems 2019 · Gangrene - StatPearls (NCBI Bookshelf NBK560552) - https://www.ncbi.nlm.nih.gov/books/NBK560552/: "Gas gangrene, typically caused by Clostridium species, is a life-threatening necrotizing infection requiring urgent intervention.", "Management includes prompt surgical debridement or amputation, broad-spectrum antibiotics, and, in some cases, intravenous immunoglobulin to bind and neutralize toxins." and "Surgery within 24 hours of admission significantly improves survival." · Egyptian National Drug Formulary - Antimicrobial 2023 (piperacillin and tazobactam monograph, p368) · Egyptian National Drug Formulary - Antimicrobial 2023 (vancomycin monograph, p333) · Egyptian National Drug Formulary - Antimicrobial 2023 (piperacillin and tazobactam monograph, p368) - severe infections 4.5 g every 6 to 8 hours by the traditional 30-minute infusion, 4.5 g every 6 hours for Pseudomonas aeruginosa cover, usual maximum 18 g per day. The adult figures are the combined amount of both components. The formulary names ischaemic and diabetic foot infections among the indications. · Egyptian National Drug Formulary - Antimicrobial 2023 (vancomycin monograph, p333) - for life-threatening systemic infection, intermittent infusion of 15 to 20 mg/kg per dose rounded to the nearest 250 mg every 8 to 12 hours, with a 20 to 35 mg/kg loading dose to a maximum of 3 g per dose in a seriously ill patient with suspected or documented MRSA.

Verified against5 documents
  • Gangrene - StatPearls (NCBI Bookshelf NBK560552) - https://www.ncbi.nlm.nih.gov/books/NBK560552/: "Gas gangrene, typically caused by Clostridium species, is a life-threatening necrotizing infection requiring urgent intervention.", "Management includes prompt surgical debridement or amputation, broad-spectrum antibiotics, and, in some cases, intravenous immunoglobulin to bind and neutralize toxins." and "Surgery within 24 hours of admission significantly improves survival."
  • Egyptian National Drug Formulary - Antimicrobial 2023 (piperacillin and tazobactam monograph, p368)
  • Egyptian National Drug Formulary - Antimicrobial 2023 (vancomycin monograph, p333)
  • Egyptian National Drug Formulary - Antimicrobial 2023 (piperacillin and tazobactam monograph, p368) - severe infections 4.5 g every 6 to 8 hours by the traditional 30-minute infusion, 4.5 g every 6 hours for Pseudomonas aeruginosa cover, usual maximum 18 g per day. The adult figures are the combined amount of both components. The formulary names ischaemic and diabetic foot infections among the indications.
  • Egyptian National Drug Formulary - Antimicrobial 2023 (vancomycin monograph, p333) - for life-threatening systemic infection, intermittent infusion of 15 to 20 mg/kg per dose rounded to the nearest 250 mg every 8 to 12 hours, with a 20 to 35 mg/kg loading dose to a maximum of 3 g per dose in a seriously ill patient with suspected or documented MRSA.

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (7)

  • Dry gangrene causes throbbing or burning pain along with claudication and rest pain [burning pain · claudication · gangrene]
  • Limb pain typically worsens when the leg is raised and eases when it hangs down [foot pain]
  • In patients with pre-existing neuropathy, visible tissue loss can be the first clue to ischemia rather than pain [ischaemia]
  • Depending on the underlying cause, dizziness, altered mental status, headache, or priapism may accompany it [dizziness · headache]
  • Wet gangrene develops from a diabetic or ischemic ulcer that drains and swells before the area darkens [gangrene · ischaemia]
  • Pain over intact-looking skin can be the only clue to a deeper abscess [abscess · foot pain]
  • Gas gangrene often follows recent trauma or surgery, with pain far out of proportion to how the skin looks [foot pain · gangrene]

Signs — what you find (7)

  • Dependent rubor when the leg hangs down, pallor on elevation, slow capillary refill, hair loss, and absent distal pulses mark ischemic gangrene [cold peripheries · hair loss · pallor]
  • Ulcer location is a clue - arterial ulcers sit on the toes and distal foot, venous ulcers over the ankle bones, neuropathic ulcers on pressure points
  • In severe acute limb ischemia, sensory loss ranges from mild toe numbness to permanent nerve damage with paralysis, and even venous flow becomes inaudible [ischaemia · numbness · paralysis]
  • Wet gangrene can show bullae, bruising, crepitus, and numbness, along with systemic signs of infection [blisters · bruising · crepitus · gangrene · numbness]
  • A red patch of gas gangrene can turn dusky with blood-filled blisters within 24 to 72 hours of the injury [blisters · gangrene]
  • Dry gangrene is worst in the digits, where the death of tissue often rings the whole toe, and the dead part dries out and can drop off by itself [gangrene]
  • Wet gangrene is dead tissue that has become infected, usually in the lower limb, and it shows swelling, redness and pus draining out [gangrene · pus · redness]

Tests (6)

  • An ankle-brachial index under 1.0 is abnormal; an ankle pressure below 40 to 60 mmHg signals ischemia
  • Deep wound cultures or aspirate, not a superficial swab, should guide antibiotic choice when gas or wet gangrene is suspected
  • A raised CRP tracks with gas gangrene, while high interleukin-6, procalcitonin, and a low hematocrit predict higher mortality
  • Plain x-ray can reveal gas under the skin, while CT shows fascial thickening or fluid pockets within muscle
  • Grayish dishwater-like fluid and fascial planes that separate easily on blunt exploration point to a necrotizing infection
  • Red flag: gas gangrene kills often, and most often when the white cell count is high, the blood sugar is high, or there is sepsis

If not this — what else fits (2)

  • Necrotizing fasciitis, often from group A strep, involves the fascia and subcutaneous tissue while sparing muscle
  • Toxic shock syndrome, an intra-abdominal abscess, and Vibrio vulnificus infection can mimic gangrene's presentation

SourceStatPearls "Gangrene" - disease-level clinical article

Presentation findings are traced to the source above.

Combination safety

Combination regimens

!! MULTI-DRUG REGIMEN - all 2 drugs are given TOGETHER. Not a choice between them.

!! the regimen: Piperacillin + Tazobactam + Vancomycin

Rx: Empiric intravenous cover, given in hospital | Main treatment

EMPIRIC INTRAVENOUS COVER, GIVEN IN HOSPITAL - give all together

1

PIPERACILLIN + TAZOBACTAM

Empiric intravenous cover, given in hospital

Regimen: gangrene-empiric-iv

1 of 2 - GIVE ALL TOGETHER

Strength4500 mg

Forminjection

Adult dose and duration

4.5 g intravenously every 6 to 8 hours for a severe infection, and every 6 hours where Pseudomonas has to be covered. Maximum 18 g in a day. - Reviewed against deep tissue culture and narrowed as soon as the organism is known

Paediatric dose

No weight grid is drawn here on purpose, because the formulary states the adult dose as the combined amount of both drugs and the paediatric dose as the piperacillin component alone, and mixing the two would print the wrong number. The formulary's paediatric figures, of piperacillin: from 2 months of age, 240 to 300 mg/kg/day divided into 3 or 4 doses, maximum 16 g/day; neonates 30 weeks or less, 100 mg/kg every 8 hours. A child with gangrene is a paediatric surgical emergency and the dose is calculated by the receiving team.

AWaRe

WATCH group - carries resistance cost. Egyptian EML 2025.

Dose source

Egyptian National Drug Formulary - Antimicrobial 2023 (piperacillin and tazobactam monograph, p368) - severe infections 4.5 g every 6 to 8 hours by the traditional 30-minute infusion, 4.5 g every 6 hours for Pseudomonas aeruginosa cover, usual maximum 18 g per day. The adult figures are the combined amount of both components. The formulary names ischaemic and diabetic foot infections among the indications.

Why

The gangrene article's empiric regimens include vancomycin with piperacillin-tazobactam, and it asks for initial broad-spectrum coverage of gram-positive, gram-negative and anaerobic organisms, broadened in a patient with diabetes to include MRSA and further gram-negatives. Four 4.5 g products are marketed in Egypt, from PIPERACILLIN-TAZOBACTAM SANDOZ at about 110 EGP to TAZOCIN at about 225 EGP; a 2.25 g presentation is also registered, which matters because the reduced renal doses are written at that strength.

Cautions
  • GIVEN ALONGSIDE VANCOMYCIN, NOT INSTEAD OF IT. The article's empiric regimen is both drugs; either alone leaves a gap.
  • The referral comes first and this is not started in a clinic. The article reports that surgery within 24 hours of admission significantly improves survival, and that prompt debridement or amputation is what controls the source - antibiotics do not substitute for it.
  • Contraindicated in hypersensitivity to penicillins, cephalosporins or beta-lactamase inhibitors.
  • The dose comes down in renal impairment: the formulary gives 4.5 g every 8 hours below a creatinine clearance of 40 mL/min and every 12 hours below 20 mL/min.
  • Take deep tissue for culture before the first dose wherever that does not delay it - the article warns that superficial swabs are contaminated by skin flora and that deep swabbing or aspiration of pus is what identifies the organism.
Egyptian brands
Egyptian brandManufacturerIndicative price
PIPERACILLIN-TAZOBACTAM SANDOZ 4.5 GM PD. FOR I.V. VIALSANDOZ110.50 EGP
PIPRATAZ 4.5 GM PD. I.V. VIALLABORATORIO REIG JOFRE > HIKMA PHARMA220.00 EGP
TAZOCIN 4.5 GM PD. FOR I.V. VIALWYETH > PFIZER225.00 EGP
PIPERACILLIN/TAZOBACTAM KABI 4.5 GM 10 PD. FOR I.V. VIALFRESENIUS KABI2570.00 EGP
2

VANCOMYCIN

Empiric intravenous cover, given in hospital

Regimen: gangrene-empiric-iv

2 of 2 - GIVE ALL TOGETHER

Strength1000 mg

Forminjection

Adult dose and duration

15 to 20 mg/kg per dose, rounded to the nearest 250 mg, by intermittent infusion every 8 to 12 hours. In a seriously ill patient with suspected or documented MRSA a loading dose of 20 to 35 mg/kg on actual body weight, to a maximum of 3 g, may be given first. - Adjusted against serum concentrations and narrowed once cultures are back

Paediatric dose

45-60 mg/kg/day

(Infants, children and adolescents: 45 to 60 mg/kg/day intravenously divided every 6 to 8 hours, individualised against serum concentrations, with the dose reduced in renal impairment. No ceiling is printed above because the formulary states none for this general band; its separate serious-MRSA bands do carry one, and they differ by age: 60 to 80 mg/kg/day divided every 6 hours from 3 months to under 12 years, and 60 to 70 mg/kg/day divided every 6 to 8 hours from 12 years, each to an initial maximum of 3,600 mg/day. Neonates: 15 mg/kg initially, then 10 mg/kg every 12 hours under 1 week of age and every 8 hours from 1 week to 1 month.)

Dose by weight
3kg135-180 mg/day
4kg180-240 mg/day
5kg225-300 mg/day
6kg270-360 mg/day
7kg315-420 mg/day
8kg360-480 mg/day
9kg405-540 mg/day
10kg450-600 mg/day
11kg495-660 mg/day
12kg540-720 mg/day
13kg585-780 mg/day
14kg630-840 mg/day
15kg675-900 mg/day
16kg720-960 mg/day
17kg765-1020 mg/day
18kg810-1080 mg/day
19kg855-1140 mg/day
20kg900-1200 mg/day
21kg945-1260 mg/day
22kg990-1320 mg/day
23kg1035-1380 mg/day
24kg1080-1440 mg/day
25kg1125-1500 mg/day
26kg1170-1560 mg/day
27kg1215-1620 mg/day
28kg1260-1680 mg/day
29kg1305-1740 mg/day
30kg1350-1800 mg/day
31kg1395-1860 mg/day
32kg1440-1920 mg/day
33kg1485-1980 mg/day
34kg1530-2040 mg/day
35kg1575-2100 mg/day
36kg1620-2160 mg/day
37kg1665-2220 mg/day
38kg1710-2280 mg/day
39kg1755-2340 mg/day
40kg1800-2400 mg/day
41kg1845-2460 mg/day
42kg1890-2520 mg/day
43kg1935-2580 mg/day
44kg1980-2640 mg/day
45kg2025-2700 mg/day
46kg2070-2760 mg/day
47kg2115-2820 mg/day
48kg2160-2880 mg/day
49kg2205-2940 mg/day
50kg2250-3000 mg/day
AWaRe

WATCH group - carries resistance cost. Egyptian EML 2025.

Dose source

Egyptian National Drug Formulary - Antimicrobial 2023 (vancomycin monograph, p333) - for life-threatening systemic infection, intermittent infusion of 15 to 20 mg/kg per dose rounded to the nearest 250 mg every 8 to 12 hours, with a 20 to 35 mg/kg loading dose to a maximum of 3 g per dose in a seriously ill patient with suspected or documented MRSA.

Why

The article pairs vancomycin with piperacillin-tazobactam as an empiric regimen for gas gangrene and necrotising soft tissue infection, and asks for MRSA cover in a patient with diabetes. The formulary lists serious skin and skin structure infection caused by methicillin-resistant staphylococci, and empiric therapy where they are suspected, among its indications. Seven 1 g vials are marketed in Egypt, from VANCOMIX at about 95 EGP to about 204 EGP, and 500 mg vials are registered as well.

Cautions
  • GIVEN ALONGSIDE PIPERACILLIN-TAZOBACTAM, NOT INSTEAD OF IT.
  • The referral and the surgery come first. This is hospital treatment, written here so the referral is an informed one.
  • Serum levels have to be monitored, and the formulary asks for early and frequent monitoring whenever empiric doses exceed 4 g/day. Nephrotoxicity and ototoxicity are the reasons.
  • The article states that if group A Streptococcus or Clostridium species are identified, the treatment becomes penicillin combined with clindamycin for 10 to 14 days, clindamycin being added to shut down toxin production; it warns that clindamycin alone is not used, because of inducible resistance. That switch is made by the treating team once the organism is known.
  • Contraindicated in hypersensitivity to vancomycin.
  • The article also records intravenous immunoglobulin as sometimes used to bind and neutralise the toxins of Clostridium, Staphylococcus and Streptococcus species, without stating a dose.
Egyptian brands
Egyptian brandManufacturerIndicative price
VANCOMIX 1G I.V. VIALSIGMA TEC95.00 EGP
VANCOLON 1000MG I.V. VIALJULPHAR165.50 EGP
VANCOGUT 1000 MG PD. FOR I.V. INF. VIALARABCOMED174.00 EGP
VETOVANCIN 1 GM I.V. VIALSIGMA TEC > VETOPHARM-EGYPT176.00 EGP
EDICIN 1 GM PD. FOR I.V. INF. VIALGLOBAL PHARMACEUTICAL INDUSTRIES204.00 EGP
VANCOBACT 1 GM VIAL FOR I.V. INF.ARABCOMED-EGYPT > EGYPHARMA-EGYPT204.00 EGP
VANCOMYCINE VIATRIS 1 GM VIALVIANAX - GREECE > ONE PHARMA MEDICS204.00 EGP

MAIN TREATMENT

3

REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)

1st line
Adult dose and duration

Immediate emergency transfer to a hospital with vascular surgery and diabetic foot capabilities for urgent debridement, revascularization assessment, deep tissue culture, and intravenous broad-spectrum antibiotic therapy. - Immediate emergency transfer

Paediatric dose

Pediatric gangrene (rare, e.g. meningococcemia, purpura fulminans, or severe vascular ischemia) requires immediate emergency transfer to a pediatric intensive care and pediatric surgical center.

Dose source

Gangrene - StatPearls (NCBI Bookshelf NBK560552) - https://www.ncbi.nlm.nih.gov/books/NBK560552/: "Gas gangrene, typically caused by Clostridium species, is a life-threatening necrotizing infection requiring urgent intervention.", "Management includes prompt surgical debridement or amputation, broad-spectrum antibiotics, and, in some cases, intravenous immunoglobulin to bind and neutralize toxins." and "Surgery within 24 hours of admission significantly improves survival."

Why

Diabetic foot gangrene is a time-critical, limb- and life-threatening emergency requiring emergency surgical intervention and parenteral antibiotics rather than primary care management.

Cautions
  • TIME-CRITICAL SURGICAL EMERGENCY: Wet gangrene, gas gangrene, systemic sepsis, or ascending erythema/crepitus require emergency hospital transport within hours.
  • Do NOT delay emergency transfer for outpatient oral antibiotic trials, topical antiseptics, or wound dressings in primary care.
  • Assess peripheral arterial pulses (dorsalis pedis, posterior tibial), check for loss of protective sensation, and monitor for systemic inflammatory response syndrome (fever, hypotension, tachycardia).

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.